Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro
- 1 March 1999
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 83 (5) , 3-12
- https://doi.org/10.1016/s0002-9149(99)00042-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Sildenafil citrate and blood-pressure–lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonistThe American Journal of Cardiology, 1999
- Clinical safety of oral sildenafil citrate (VIAGRATM) in the treatment of erectile dysfunctionInternational Journal Of Impotence Research, 1998
- EFFECTS OF SILDENAFIL ON THE RELAXATION OF HUMAN CORPUS CAVERNOSUM TISSUE IN VITRO AND ON THE ACTIVITIES OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ISOZYMESJournal of Urology, 1998
- Oral Sildenafil in the Treatment of Erectile DysfunctionNew England Journal of Medicine, 1998
- Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cellsLife Sciences, 1998
- Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1C) is induced in human arterial smooth muscle cells of the synthetic, proliferative phenotype.Journal of Clinical Investigation, 1997
- ANTI-PLATELET ACTION OF NITRIC OXIDE AND SELECTIVE PHOSPHODIESTERASE INHIBITORSShock, 1997
- Nitric Oxide in the Regulation of Blood Flow and Arterial PressureAnnual Review of Physiology, 1995
- Current Status of Phosphodiesterase Inhibitors in the Treatment of Congestive Heart FailureDrugs, 1992
- EFFECTS OF ENDOTHELIUM-DERIVED NITRIC OXIDE ON PERIPHERAL ARTERIOLAR TONE IN MANThe Lancet, 1989